Status:
COMPLETED
Choice Architecture Based TB Preventive Therapy Prescribing
Lead Sponsor:
Johns Hopkins University
Collaborating Sponsors:
KNCV Tuberculosis Foundation
Clinton Health Access Initiative, Zimbabwe
Conditions:
HIV/AIDS
Tuberculosis
Eligibility:
All Genders
Phase:
NA
Brief Summary
Background: Clinical guidelines and policies often fail to achieve high levels of delivery of intended clinical interventions. The difference in what investigators know works and what is actually deli...
Detailed Description
BACKGROUND Clinical guidelines and policies often fail to achieve high levels of delivery of the intended clinical intervention. The difference in what investigators know works and what is actually d...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- As this is a health system strategy with the intervention at the clinic level, all adult PWH receiving care at that clinic will be exposed to the strategy and included in the overall proportion of PWH seen at the clinic during the study period who receive 3HP
- Exclusion criteria:
- None
Exclusion
Key Trial Info
Start Date :
March 29 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 31 2022
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT04466293
Start Date
March 29 2021
End Date
October 31 2022
Last Update
August 12 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
KNCV Tuberculosis Foundation
Lilongwe, Malawi
2
Aurum Institute
Maputo, Mozambique
3
Clinton Health Access Initiative
Harare, Zimbabwe